Faecal calprotectin — a useful tool in the management of inflammatory bowel disease
This review highlights the role of faecal calprotectin as a non-invasive biomarker in managing inflammatory bowel disease (IBD). Elevated faecal calprotectin levels reliably differentiate IBD from non-inflammatory gastrointestinal disorders, correlate with disease activity assessed via endoscopy and histology, and predict relapse within 12 months for patients in clinical remission. While
June 26, 2025
No Comments